575 related articles for article (PubMed ID: 11439095)
1. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
2. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery.
Tsoukatos DC; Brochériou I; Moussis V; Panopoulou CP; Christofidou ED; Koussissis S; Sismanidis S; Ninio E; Siminelakis S
J Lipid Res; 2008 Oct; 49(10):2240-9. PubMed ID: 18587071
[TBL] [Abstract][Full Text] [Related]
4. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
[TBL] [Abstract][Full Text] [Related]
5. Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
Stafforini DM; Prescott SM; McIntyre TM
J Biol Chem; 1987 Mar; 262(9):4223-30. PubMed ID: 3558407
[TBL] [Abstract][Full Text] [Related]
6. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
Min JH; Wilder C; Aoki J; Arai H; Inoue K; Paul L; Gelb MH
Biochemistry; 2001 Apr; 40(15):4539-49. PubMed ID: 11294621
[TBL] [Abstract][Full Text] [Related]
9. Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions.
Karabina SA; Liapikos TA; Grekas G; Goudevenos J; Tselepis AD
Biochim Biophys Acta; 1994 Jun; 1213(1):34-8. PubMed ID: 8011677
[TBL] [Abstract][Full Text] [Related]
10. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation.
Androulakis N; Durand H; Ninio E; Tsoukatos DC
J Lipid Res; 2005 Sep; 46(9):1923-32. PubMed ID: 15995176
[TBL] [Abstract][Full Text] [Related]
11. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
Stafforini DM; McIntyre TM; Carter ME; Prescott SM
J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
[TBL] [Abstract][Full Text] [Related]
12. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
Subramanian VS; Goyal J; Miwa M; Sugatami J; Akiyama M; Liu M; Subbaiah PV
Biochim Biophys Acta; 1999 Jul; 1439(1):95-109. PubMed ID: 10395969
[TBL] [Abstract][Full Text] [Related]
13. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
[TBL] [Abstract][Full Text] [Related]
14. The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells.
Balestrieri ML; Servillo L; Lee T
J Biol Chem; 1997 Jul; 272(28):17431-7. PubMed ID: 9211886
[TBL] [Abstract][Full Text] [Related]
15. Effect of platelet activating factor on the kinetics of LDL oxidation in vitro.
Deigner HP; Dresel HA
FEBS Lett; 1993 Feb; 317(3):202-6. PubMed ID: 8425606
[TBL] [Abstract][Full Text] [Related]
16. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
Tselepis AD; John Chapman M
Atheroscler Suppl; 2002 Dec; 3(4):57-68. PubMed ID: 12573364
[TBL] [Abstract][Full Text] [Related]
18. A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acyl analogs of platelet-activating factor (PAF) with PAF as the acetate donor in HL-60 cells.
Lee TC; Uemura Y; Snyder F
J Biol Chem; 1992 Oct; 267(28):19992-20001. PubMed ID: 1400315
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone.
Bittman R; Witzke NM; Lee TC; Blank ML; Snyder F
J Lipid Res; 1987 Jun; 28(6):733-8. PubMed ID: 3611974
[TBL] [Abstract][Full Text] [Related]
20. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities.
Baker RR; Chang H
Biochim Biophys Acta; 1998 Jun; 1392(2-3):351-60. PubMed ID: 9630721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
